Suppr超能文献

肾移植后药物不依从的预测因素:一项法国观察性研究。

Factors predictive of medication nonadherence after renal transplantation: a French observational study.

机构信息

CHU de Bordeaux, Hôpital Pellegrin, Service de Néphrologie et Transplantation Rénale, Bordeaux, France.

出版信息

Transplantation. 2013 Jan 27;95(2):326-32. doi: 10.1097/TP.0b013e318271d7c1.

Abstract

BACKGROUND

There have been few prospective studies on the natural history of nonadherence (NA) in kidney transplant recipients (KTRs) over time. The objective of this study was to prospectively evaluate the rate of and risk factors for NA in a French cohort of KTRs.

METHOD

A total of 312 KTRs from eight French transplantation centers were included in this prospective, noninterventional cohort study. A computer-learning software package (the Organ Transplant Information System) was made available to all patients.

RESULTS

Using the four-item Morisky scale, we showed that 17.3%, 24.1%, 30.7%, and 34.6% of patients were nonadherent at posttransplant month 3 (M3), M6, M12, and M24, respectively. Young age was predictive of NA at M6, M12, and M24. Surprisingly, simple treatment regimens including a small number of doses per day and a small number of tablets per day were associated with NA at M3 and M12, respectively. Other factors predictive of NA included failure to use the Organ Transplant Information System software package at M6 and patient reports of adverse events at M12 and M24. Importantly, we observed that physicians underestimated the prevalence of adverse events when compared to patient self-reporting.

CONCLUSION

Our observed rate of medication NA in France is consistent with rates reported in previous studies. We found variability in NA risk factors over time as well as an unexpected risk factor (simple treatment regimens). These findings will be useful in developing effective adherence-promoting interventions.

摘要

背景

针对肾移植受者(KTR)随时间推移不依从(NA)的自然病史,此前鲜有前瞻性研究。本研究旨在前瞻性评估法国 KTR 队列中 NA 的发生率和危险因素。

方法

本前瞻性、非干预性队列研究共纳入来自法国 8 个移植中心的 312 名 KTR。为所有患者提供了一个计算机学习软件包(器官移植信息系统)。

结果

使用四项 Morisky 量表,我们显示,分别在移植后第 3 个月(M3)、第 6 个月(M6)、第 12 个月(M12)和第 24 个月(M24),17.3%、24.1%、30.7%和 34.6%的患者出现 NA。年轻是 M6、M12 和 M24 时出现 NA 的预测因素。令人惊讶的是,每天剂量少和每天片剂少的简单治疗方案分别与 M3 和 M12 时的 NA 相关。其他预测 NA 的因素包括在 M6 时未使用器官移植信息系统软件包以及在 M12 和 M24 时报告的不良事件。重要的是,与患者自我报告相比,我们观察到医生低估了不良事件的发生率。

结论

我们观察到的法国药物 NA 发生率与之前研究报告的发生率一致。我们发现,NA 的危险因素随时间而变化,且存在一个意外的危险因素(简单的治疗方案)。这些发现将有助于开发有效的依从性促进干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验